Newsletter Signup
Video
Podcast
Contact Us
Advertise
Magazine
Log In
Register
Facebook icon
Twitter icon
YouTube icon
Instagram icon
LinkedIn icon
Automation
Finishing World
Made in America
New Products
Operations
Product Development
Safety
Software
Supply Chain
Home
Operations
Geoff Mulvihill
Associated Press
More from Geoff Mulvihill
Regulation
Purdue Pharma, U.S. States Agree to New Opioid Settlement
It could be more than $10 billion.
Regulation
OxyContin Maker's Settlement Goes to Judge for Confirmation
It comes nearly two years after seeking bankruptcy protection.
Regulation
OxyContin Maker Pleads Guilty in Criminal Case
Purdue Pharma admitted impeding the U.S. Drug Enforcement Administration's efforts to combat the addiction crisis.
Regulation
Judge: Purdue Pharma Must Halt Some Political Contributions
Purdue contributed to attorneys general associations even while negotiating a settlement with states over the opioid crisis.
Supply Chain
Creative Hunt for Supplies
The federal cupboard is officially bare.
Operations
Generic Drugmakers Sold Most Opioids During Overdose Crisis
Court documents reveal a company culture that allowed Mallinckrodt to become one of the giants of the prescription opioid market.
Regulation
Drugmaker Reaches $1.6B Opioid Settlement
The deal is intended to end hundreds of lawsuits faced by the company over opioids.
Regulation
Purdue Pharma Starts Claim Campaign
It tells people where they can file claims against the company.
Regulation
Bankruptcy Judge Considers Purdue Pharma CEO's $1.3M Bonus
Purdue says maintaining its bonus program is essential to keep employees on the job and performing.
Operations
Purdue Paid CEO $9M Before Bankruptcy
Five other board members overseeing the private company were paid a combined $3.7 million over that span.
Operations
Companies Reach $260M Deal to Settle Opioids Lawsuit
The settlement ends only the suits brought by the Ohio counties of Cuyahoga and Summit.
Regulation
Opioid Industry Presses for Settlement
The talks involve the distributors AmerisourceBergen, Cardinal Health and McKesson, as well as drug makers Johnson & Johnson and Teva.